经皮给药新型脂质体——二元醇质体的研究进展

经皮给药新型脂质体——二元醇质体的研究进展

邢文善,路芳,徐阳

长春医学高等专科学校药学系药剂教研室,长春医学高等专科学校药学系药剂教研室,长春医学高等专科学校药学系药剂教研室

收稿日期:2018-02-07 修回日期:2018-02-07 出版日期:2018-04-25

Progress in the Study of Novel Liposome—Binary Ethosomes for Percutaneous Administration

XING Wenshan,LU Fang and XU Yang

Department of Pharmacy,Changchun Medical College,长春医学高等专科学校药学系药剂教研室,长春医学高等专科学校药学系药剂教研室

Received:2018-02-07 Revised:2018-02-07 Online:2018-04-25

摘要/Abstract

摘要： 二元醇质体是一种新型经皮给药载体，可认为是一种特殊的脂质体，与普通脂质体相比，二元醇质体中添加了较高浓度的醇（乙醇、丙二醇），形成渗透性、皮肤滞药量及包封率更好的脂质囊泡，其凝胶制剂更优，并具有优良的稳定性和皮肤耐受性，因此，二元醇质体成为近几年经皮给药研究的热点。本文在其透皮机理、性质、特点、应用及研究前景方面进行简单综述。

Abstract: Binary ethosomes is a novel transdermal drug delivery carrier， which can be considered as a special liposome. Compared with ordinary liposomes， higher concentrations of alcohol (ethanol， propanediol) were added to binary ethosomes to form lipid vesicles with better permeability， skin drug retention and encapsulation efficiency. The gel preparation is better. Because of its excellent stability and skin tolerance， binary ethosomes has become the focus of transdermal drug delivery in recent years. In this paper， the transdermal mechanism， properties， characteristics， applications and research prospects of binary ethosomes were briefly reviewed.

邢文善,路芳,徐阳. 经皮给药新型脂质体——二元醇质体的研究进展[J]. .

XING Wenshan,LU Fang and XU Yang. Progress in the Study of Novel Liposome—Binary Ethosomes for Percutaneous Administration[J]. .

参考文献

[1] 李理宇,王洪权.新型经皮给药载体-醇质体的研究进展[J].中国新药杂志,2010,19(1)：33-38.
[2] Fang YP, Tsaiyh, Wu PC, et al． Comparison of 5- aminolevu- linic acid- encapsulated liposome versus ethosome for skin delivery for photodynamic therapy[J]． Int J Pham, 2008, 356(1/2):144 －152．
[3] 向大雄,赵梦丹,罗杰英,等. 皮肤局部用脂质体的制备与评价[J]. 中国药房,2005,16(5) ：384-387.
[4] Manconi M, Mura S, Sinico C, et al． Development and characterization of liposomes containing glycols as carriers for diclofenac[ J]． Colloids Surf A, 2009, 242: 53 －58．
[5] Zhou Y, Wei Y, Liu H, et al． Preparation and in vitro evaluation ofethosomal total alkaloids of Sophora alopecuroides loaded by atransmembrane pH gradient method[J] ． Pharm Sci Tech, 2010,11: 1350 －1358．
[6] 王慧．盐酸阿莫罗芬乙醇脂质体及尼古丁二元醇脂质体的制备与评价[ D] ．兰州:兰州大学, 2010．
[7] ZHOU Yan, WEI Yuhui, LIU Huanxiang, et al． Preparation and in vitro evaluation of ethosomal total alkaloids of Sophora alopecuroides loaded by a transmembrane pH- gradient method[ J] ． AAPS Pharm Sci Tech, 2010, 11(3):1350- 1358．
[8] 祝伟伟,翟光喜,赵军．醇质体的研究进展[J].食品与药品,2007,9(01A)：46-49.[ ] Touitou E, Dayan N, Bergelson L, et al. Ethosomes梟ovel vesicular carriers for enhanced delivery: characterization and skin penetration properties[J]. J Control Release, 2000, 65:403-418.
[9] 何一鸣,何卓儒,朱秀城,等. 盐酸特比萘芬二元醇质体的制备及体外评价[J].广东药学院学报,2015,31(2):1-6.
[10]王军,何文.酮洛芬二元醇质体凝胶的研制及其质量考察[J].中国药师,2012,15(6)：780-782.
[11]王慧,张晓红,张燕,杨苗苗,陈奕晨,等.乙醇脂质体、二元醇脂质体及传递体对多奈哌齐经皮转运的对比性研究
[12] 袁海玲.三种新型布洛芬透皮脂质囊泡的比较及二元醇脂质体温敏凝胶的制备与评价[D] ．兰州:兰州大学, 2014．
[13]张建萍.三种新型透皮脂质囊泡的比较研究[D] ．兰州:兰州大学, 2012．
[14] Touitou E, Dayan N, Bergelson L, et al. Ethosomes梟ovel vesicular carriers for enhanced delivery: characterization and skin penetration properties[J]. J Control Release, 2000, 65:403-418.
[15] 谢志勇,王军. 酮洛芬一元与二元醇质体凝胶稳定性及体外透皮性的比较研究[J].山西医科大学学报,2013,44(7):539-542.
[16] 金思岑.正交试验法优选黄芩苷二元醇质体制备工艺[J].中国药房,2013,24(19)：1777-1779
[17] 何冰倩,李俊丽,刘小平,等.苦参碱二元醇质体的制备及其质量评价[J].中成药,2014,36(8)：1770-1773.
[18] 王慧,张晓红,张燕,杨苗苗,陈奕晨,等.乙醇脂质体、二元醇脂质体及传递体对多奈哌齐经皮转运的对比性研究
[19]危红华,赵晓旭,李莎莎,等.苦参方二元醇质体凝胶剂的制备及体外经皮给药研究[J].中华中医药杂志,2013,28(9)：2762-2766.
[20]张玲莉,韩瑞玲.酮洛芬二元醇质体凝胶抗炎镇痛作用考察[J].中国药师,2013,16(10)：1537-1539.
[21] 袁海玲.三种新型布洛芬透皮脂质囊泡的比较及二元醇脂质体温敏凝胶的制备与评价[D] ．兰州:兰州大学, 2014．
[22]宋玲,张玲莉,袁李芳. 盐酸青藤碱二元醇质体的抗炎镇痛作用及皮肤刺激性研究[J].广东药学院学报,2013,29(4)：403-406.
[23] Howitz E, Pisanty S, Czerninski R, et al. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1999, 87(6): 700-705.

快速检索引用检索图表检索高级检索